Era of surrogate endpoints and accelerated approvals: a comprehensive review on applicability, uncertainties, and challenges from regulatory, payer, and patient perspectives.
Saved in:
| Title: | Era of surrogate endpoints and accelerated approvals: a comprehensive review on applicability, uncertainties, and challenges from regulatory, payer, and patient perspectives. |
|---|---|
| Authors: | Sharma R; University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India. rsharma.heor@gmail.com., Gulati A; Centre for Studies in Science Policy, School of Social Sciences, Jawaharlal Nehru University, New Delhi, India., Chopra K; University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India. k.chopra@pu.ac.in.; Pharmacology Research Laboratory, UGC Centre of Advanced Studies, University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh, 160014, India. k.chopra@pu.ac.in. |
| Source: | European journal of clinical pharmacology [Eur J Clin Pharmacol] 2025 May; Vol. 81 (5), pp. 605-623. Date of Electronic Publication: 2025 Mar 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-1041 |
|---|---|
| DOI: | 10.1007/s00228-025-03822-w |
